October 6, 2026
Bonus Content: RXO Jumps 22%, CHRW Drops 11%: One Deal, Two Verdicts
Editor’s Note: See the following from Joel Litman, Chief Investment Officer and Analyst at Altimetry, whose followers include names at Fidelity, BlackRock, Vanguard, and half of the top 300 money management firms in America. Joel has deep ties to Washington, DC and he’s consulted for the Pentagon, the FBI, the Department of Defense, and has lectured at the US Marine Corps War College. Today he secured access to one of the most heavily guarded areas in the world to uncover the truth about what could soon become the biggest stock market story of the decade.
Dear Reader,
For years, we’ve been told SpaceX is a rocket company… that will one day take humans to Mars (and the moon).
But according to new satellite images from 300 miles above the Earth’s surface, there is something very strange going on at SpaceX right now that has nothing to do with space.
A new division of SpaceX is deploying a new way to power our world… that could replace our need for foreign oil forever – without using nuclear fission, solar, wind, geothermal, coal, or any sort of battery.
When you consider SpaceX burns 29,600 gallons of fuel per launch… it makes sense the business would want a better way to generate energy.
But what it’s doing right now could change not only SpaceX’s operations… but also dramatically affect the entire country – and your investments.
What it’s deploying is a newly permitted technology I know simply as “Dark Energy.”
Most people have no idea something like this is even possible.
And it will sound like science fiction – at first.
But as I prove in my new boots-on-the-ground interview from West Texas, this is the beginning of what could be a $10 trillion boom for investors who know what to do – and who take the right steps now.
SpaceX can’t make this “Dark Energy” by itself. It relies on a small group of little-known suppliers to make it happen.
And I believe that’s why a laundry list of billionaires and tech CEOs are getting themselves into position.
Early supporters of “Dark Energy” include Nvidia CEO Jensen Huang, Oracle founder Larry Ellison, and OpenAI CEO Sam Altman.
Not to mention names like Brad Gerstner, a legendary tech investor who managed to be early on Uber, Microsoft, Amazon, Meta, and Nvidia.
He just joined a $300 million round backing this technology.
Or Garry Tan.
Garry invested in Coinbase back in 2012… turning a $300,000 stake into $2.4 billion in less than 10 years.
He’s backed Airbnb, Stripe, DoorDash, and Dropbox… and his firm has invested in companies that are now worth more than $1 trillion combined.
Today, he’s backing “Dark Energy.”
This discovery could change our daily lives… and radically lower the cost of power.
And I believe that for you, this could be one the most profitable moments of your financial life if you position your money behind the right stocks before this news spreads.
I’m sharing all the details right now, on camera.
Click here to see how you could double your money or more by backing this new “Dark Energy.”
Regards,
Joel Litman
Chief Investment Officer, Altimetry
RXO Jumps 22%, CHRW Drops 11%: One Deal, Two Verdicts
Analyst Targets
- JPMorgan: Maintains Overweight on CHRW; cuts target to $198 from $225. Upgrades RXO to Neutral; raises target to $30.00 from $22.00.
- Jefferies: Downgrades RXO to Hold from Buy; target moves to $30.00.
- BMO Capital: Downgrades RXO to Market Perform from Outperform; target cut to $30.25 from $35.00.
- TD Cowen: Upgrades RXO to Hold from Sell; target set at $30.25 to match the offer.
Two Stocks, One Deal
The market delivered a split decision overnight. RXO surged more than 22% to around $28.65 as investors priced in the acquisition premium, while CHRW fell nearly 11% as the market weighed the cost of the deal. That divergence is the whole story in miniature: RXO shareholders get a clean exit at a meaningful premium; CHRW shareholders are left calculating whether the price was right.
Under the merger agreement, RXO shareholders receive $17.25 in cash and 0.0856 CHRW shares for each RXO share, implying total consideration of $30.25 per share, a 29% premium to RXO’s closing price on October 2, 2026.
What Each Company Is
CHRW, with a market cap in the high teens of billions of dollars, operates as a non-asset-based third-party logistics provider primarily focused on freight brokerage in truckload and less-than-truckload markets, serving retailers, manufacturers, and food and beverage producers from its Eden Prairie, Minnesota headquarters.
RXO is a Charlotte, North Carolina-based asset-light transportation company connecting shippers with carriers for truckload freight across North America, with managed transportation and last-mile delivery rounding out its platform. RXO launched in 2022 with a proprietary digital freight marketplace and access to vast truckload capacity, with complementary brokered services in managed transportation, last mile, and freight forwarding.
Together they will create a combined company with an enterprise value of over $25 billion. Pro forma revenue is expected to reach $25 billion for 2026.
The Deal Mechanics and the Bridge
Financing this at scale required real commitment from Morgan Stanley. On October 4, 2026, CHRW entered into a debt commitment letter with Morgan Stanley Senior Funding, which committed to provide a 364-day senior unsecured bridge term loan of up to $4.5 billion to finance a portion of the cash consideration, refinance RXO’s existing credit facility, and pay related fees and expenses. CHRW also confirmed that share buybacks will be paused until leverage returns to its target range after the transaction closes.
RXO shareholders are expected to own approximately 11% of the combined company, with the deal projected to be accretive to adjusted EPS within nine months of close and to generate mid-teens accretion in 2028. The synergized implied EV/2026E adjusted EBITDA multiple is 13.2x, and CHRW targets net leverage of 1.75x to 2.25x by year-end 2028.
The $300 Million Question
The entire financial case rests on one number. CHRW expects $300 million in net run-rate cost synergies within two years of closing, with management framing the opportunity as applying its Lean AI operating model and operating discipline across the combined platform. RXO will be integrated primarily into CHRW’s North American Surface Transportation division.
Macro and Industry Context
Freight brokerage has been under sustained margin pressure. Spot rates softened considerably through 2024 and 2025, compressing gross profit per load across the sector and making standalone scale harder to monetize. The consolidation rationale is clear: density lowers cost-to-serve in brokerage, and two large networks combining carrier relationships reduces duplication in a business where carrier access is table stakes.
The companies expect to close in the first half of 2027, pending regulatory approval and a vote by RXO stockholders. MFN Partners, which holds about 17% of RXO, has agreed to vote its shares in favor, and Orbis Investments, RXO’s largest shareholder, also backs the deal.
Bull / Base / Bear
Bull: The Lean AI model delivers synergies ahead of schedule. Freight markets recover through 2027, margin expansion compounds, and mid-teens EPS accretion arrives on time. CHRW re-rates toward its pre-deal analyst consensus north of $200.
Base: Integration runs on plan but takes longer than nine months to show in EPS. The bridge facility gets refinanced into permanent debt at manageable rates, leverage trends toward target by late 2028, and the deal is mildly accretive in year one.
Bear: Synergy realization slips; shared-services consolidation proves slower than modeled. Rate environment stays suppressed, buyback pause frustrates shareholders, and CHRW stays rangebound in the $130s until proof points arrive.
Technical Overlay
CHRW opened around $140 on Monday after closing around $158 on October 2, 2026. The gap down through the 50-day moving average creates a well-defined level to watch: a close back above $150 would signal the market is beginning to accept the deal’s terms. RXO, now trading near $28.65, sits roughly 5% below the $30.25 offer with merger arbitrage spread reflecting standard close-risk on a first-half 2027 timeline.
Bottom Line
CHRW’s drop is a pricing verdict, not a business verdict. The market is skeptical that $300 million in cost synergies fully justifies $4.5 billion in bridge debt and a paused buyback. What resolves that skepticism is execution: cost-to-serve metrics inside the combined NAST division by Q3 2027, and EPS accretion arriving within the nine-month window management committed to. Until those numbers land, CHRW is an integration story trading on faith in a model it has only ever applied to itself.
